Professor Peter Parker was awarded a DPhil in Biochemistry from Oxford in 1979. Following post-doctoral fellowships, and tenure-track appointment, he became a Principal Scientist at the Imperial Cancer Research Fund (to become Cancer Research UK) in 1990, and has held a joint appointment with King’s College London since 2006. His research work in cancer, along with the co-founding of companies, has led to broad interests and expertise in the dysregulation of cellular controls, in drug discovery and in biomarkers pertinent to oncology. He was elected to the European Molecular Biology Organisation in 1997, to the Academy of Medical Sciences in 2000, he was awarded the Morton Prize in 2004, elected to the Royal Society in 2006 and elected to the European Academy of Cancer Sciences in 2011. Peter is currently Director of the CRUK KHP Cancer Centre at King’s College London and is a Senior Group Leader at the Francis Crick Institute.